Heffernan signs up to ACT
This article was originally published in Clinica
Executive Summary
Regenerative medicine company Advanced Cell Technology has appointed Michael Heffernan to its board. Co-founder, president and CEO of Collegium Pharmaceutical, Mr Heffernan is also on the board at PreCision Technology, a dermatology-focused speciality pharma company he founded, Cornerstone Therapeutics and TyRx.